Selling Stem Cells
Californians are set to vote on a proposal to spend $300 million a year over the next 10 years for stem cell research. For some perspective on how big a deal this would be, the federal government spent $25 million last year. The ballot measure, known as Proposition 71, is being financially supported by a strong cadre of entertainers, business people, and others, including Nancy Reagan, as the New York Times reports today and would be a strong counteraction to the Bush administration’s ban on new stem cell lines. But is the Times overstating the number of potential beneficiaries of stem cell research? The paper writes, “half of California’s families are affected by one or more of the 70 diseases or conditions that could respond to stem cell therapies,” in which they include Alzheimer’s disease. (Approximately 500,000 Californians have Alzheimer’s disease.) But as the Washington Post reported in June, stem cells are an unlikely therapy for Alzheimers, which involves the loss of huge numbers and varieties of the brain’s 100 billion nerve cells. Lest California voters come to wonder just what they’ve been sold, it may be better to be up front about it in the first place.
Deep Dive
Uncategorized

It will soon be easy for self-driving cars to hide in plain sight. We shouldn’t let them.
If they ever hit our roads for real, other drivers need to know exactly what they are.

Maximize business value with data-driven strategies
Every organization is now collecting data, but few are truly data driven. Here are five ways data can transform your business.

Cryptocurrency fuels new business opportunities
As adoption of digital assets accelerates, companies are investing in innovative products and services.

Where to get abortion pills and how to use them
New US restrictions could turn abortion into do-it-yourself medicine, but there might be legal risks.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.